Accès à distance ? S'identifier sur le proxy UCLouvain
Challenges and Opportunities in the Development of Serine Synthetic Pathway Inhibitors for Cancer Therapy.
Primary tabs
Document type | Article de périodique (Journal article) – Synthèse de littérature |
---|---|
Access type | Accès restreint |
Publication date | 2017 |
Language | Anglais |
Journal information | "Journal of Medicinal Chemistry" - Vol. 60, no. 4, p. 1227-1237 (2017) |
Peer reviewed | yes |
Publisher | American Chemical Society ((United States) Washington, DC) |
issn | 0022-2623 |
e-issn | 1520-4804 |
Publication status | Publié |
Affiliations |
UCL
- SSS/IREC - Institut de recherche expérimentale et clinique UCL - SSS/IREC/FATH - Pôle de Pharmacologie et thérapeutique UCL - SSS/LDRI - Louvain Drug Research Institute |
Links |
Bibliographic reference | Ravez, Séverine ; Spillier, Quentin ; Marteau, Romain ; Feron, Olivier ; Frédérick, Raphaël. Challenges and Opportunities in the Development of Serine Synthetic Pathway Inhibitors for Cancer Therapy.. In: Journal of Medicinal Chemistry, Vol. 60, no. 4, p. 1227-1237 (2017) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/180991 |